Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Outcome By Primary Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A Large, Population-Based Study in Sweden

Caroline Weibull, Björn E Wahlin, MD PhD, Sandra Lockmer, Gunilla Enblad, Per-Ola Andersson, MD PhD, Eva Kimby, MD PhD, Karin E. Smedby, MD PhD

Blood (2020) 136 (Supplement 1): 46–47.

https://doi.org/10.1182/blood-2020-140228

Published: 2020

Journal Articles

Nationwide Investigation of Patient Trajectories in Mantle Cell Lymphoma - Initial Data from the Swedish MCL C omplete Project

Mats Jerkeman, MD PhD, Thorgerdur Palsdottir, Ingrid Glimelius, MD PhD, Alexandra Albertsson-Lindblad, MD PhD, Caroline Weibull, Fredrik Ellin, MD PhD, Kristina Sonnevi, MD PhD, Catharina Lewerin, MD PhD, Lena Brandefors, Karin E. Smedby, MD PhD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-133292

Published: 2020

Journal Articles

Encouraging Outcomes with Intensive Chemotherapy for Patients with Primary Mediastinal B-Cell Lymphoma - a Swedish Lymphoma Register Study

Tove Wästerlid, MD PhD, George Z. Rassidakis, MD PhD Prof., Birgitta Sander, MD PhD Prof., Karin E. Smedby, MD PhD

Blood (2019) 134 (Supplement_1): 1618.

https://doi.org/10.1182/blood-2019-122819

Published: 2019

Journal Articles

Incidence of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Including CNS Relapse in a Population-Based Cohort of 4205 Patients in Sweden

Sara Harrysson, MD, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Mats Jerkeman, MD Professor, Sverker Hasselblom, Björn E Wahlin, MD PhD, Per-Ola Andersson, MD PhD, Karin E. Smedby, MD PhD

Blood (2019) 134 (Supplement_1): 399.

https://doi.org/10.1182/blood-2019-122014

Published: 2019

Journal Articles

Autologous Stem Cell Transplantation in Mantle Cell Lymphoma - Selection Mechanisms and Survival By Age Group

Ingrid Glimelius, MD PhD, Karin E. Smedby, MD PhD, Alexandra Albertsson-Lindblad, MD PhD, Sandra Eloranta, Mats Jerkeman, MD Professor, Caroline Weibull

Blood (2019) 134 (Supplement_1): 4572.

https://doi.org/10.1182/blood-2019-124676

Published: 2019

Journal Articles

Evaluation of the NCCN-IPI As a Prognostic Tool in PTCLs

Fredrik Ellin, MD MSc, Matthew J Maurer, MS, Line Srour, MD, Umar Farooq, MD, Mats Jerkeman, MD PhD, Joseph M Connors, MD, Karin E Smedby, MD PhD, Nabila Nora Bennani, MD, Stephen M Ansell, MD PhD, Graham W Slack, MD, James R. Cerhan, MD PhD, Thomas Relander, MD PhD, Andrew L Feldman, MD, Kerry J Savage, BSc, MD MSc

Blood (2017) 130 (Supplement 1): 2795.

https://doi.org/10.1182/blood.V130.Suppl_1.2795.2795

Published: 2017

Journal Articles

PD-L1 Expression and Gene Amplification in CD30+ Diffuse Large B-Cell Lymphoma (DLBCL): Significance of TP53 Genetic Impact and Clinicopathologic Characteristics

George Rassidakis, MD PhD, Yi Miao, MD PhD, Jun Zhang, MD, Vassilis Atsaves, PhD, Lorand Kis, MD PhD, Karin E Smedby, MD PhD, Yong Li, PhD, Zijun Yidan Xu-Monette, PhD, Ken H. Young, MD PhD

Blood (2017) 130 (Supplement 1): 1475.

https://doi.org/10.1182/blood.V130.Suppl_1.1475.1475

Published: 2017

Journal Articles

Six Cycles of R-CHOP-21 Is Non-Inferior to 8 Cycles for Treatment of Diffuse Large B-Cell Lymphoma - a Nordic Lymphoma Group Population Based Study

Tove Wästerlid, MD PhD, Jorne Lionel Biccler, MSc, Peter de Nully Brown, MD PhD, Jacob Haaber Christensen, MD PhD, Gunilla Enblad, MD PhD, Judit Mészáros Jørgensen, Karin E Smedby, MD PhD, Tarec Christoffer El-Galaly, MD PhD, Mats Jerkeman, MD PhD

Blood (2017) 130 (Supplement 1): 1560.

https://doi.org/10.1182/blood.V130.Suppl_1.1560.1560

Published: 2017

Journal Articles

Common Genetic Polymorphisms Contribute to the Association between Non-Melanoma Skin Cancer and Chronic Lymphocytic Leukemia

Caroline Besson, MDPhD, Amy Moore, Wenting Wu, Nicola J Camp, PhD, Claire Vajdic, Lindsay M. Morton, PhD, Karin E Smedby, MD PhD, Silvia de Sanjose, Tait D Shanafelt, MD, Jerry Brewer, Lydia Zablotska, Eric A. Engels, MD MPH, James R. Cerhan, MD PhD, Susan L Slager, PhD, Jiali Han, Sonja I Berndt, PhD

Blood (2017) 130 (Supplement 1): 1454.

https://doi.org/10.1182/blood.V130.Suppl_1.1454.1454

Published: 2017

Journal Articles

Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors

Blood (2017) 130 (Supplement 1): 57.

https://doi.org/10.1182/blood.V130.Suppl_1.57.57

Published: 2017

Journal Articles

EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player

Blood (2015) 126 (23): 4126.

https://doi.org/10.1182/blood.V126.23.4126.4126

Published: 2015

Journal Articles

ATM Mutations in Major Stereotyped CLL Subsets: Enrichment in Subset #2 is Associated with Unfavourable Outcome

Blood (2015) 126 (23): 1712.

https://doi.org/10.1182/blood.V126.23.1712.1712

Published: 2015

Journal Articles

Event-Free Survival at 12 Months and Subsequent Overall Survival in Patients with Peripheral T-Cell Lymphoma

Matthew J Maurer, MS, Fredrik Ellin, MD MSc, James Cerhan, MD PhD, Stephen Ansell, MD PhD, Brian K Link, MD, Mats Jerkeman, MD PhD, Karin E Smedby, MD PhD, Carrie A. Thompson, MD, William Macon, MD, Sergei Syrbu, MD, Susan L. Slager, PhD, Thomas E. Witzig, MD, Thomas M. Habermann, MD, Thomas Relander, MD PhD, Andrew L Feldman, MD

Blood (2015) 126 (23): 1501.

https://doi.org/10.1182/blood.V126.23.1501.1501

Published: 2015

Journal Articles

CLL with Mutated IGHV4-34 Antigen Receptors Is Clinically Heterogeneous: Antigen Receptor Stereotypy Makes the Difference

Aliki Xochelli, Panagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, Lesley-Ann Sutton, Eva Minga, Eugen Tausch, MD, Xiao J. Yan, Tait D. Shanafelt, MD, Karla Plevova, PhD, Myriam Boudjogra, Davide Rossi, MD PhD, Zadie Davis, Alba Navarro, Yorick Sandberg, Fie Juhl Vojdeman, Lydia Scarfo, Niki Stavroyianni, Andrey B. Sudarikov, PhD, Silvio Veronese, Tatiana Tzenou, MD, Teodora Karan-Djurasevic, Mark Catherwood, PhD, Dirk Kienle, Maria Chatzouli, Monica Facco, MS, Jasmin Bahlo, Lone Bredo Pedersen, Larry Mansouri, Karin E Smedby, MD PhD, Charles C Chu, Véronique Giudicelli, Marie-Paule Lefranc, Panagiotis Panagiotidis, Gunnar Juliusson, Achilles Anagnostopoulos, Darko Antic, Livio Trentin, Marco Montillo, Carsten Niemann, Hartmut Döhner, MD, Anton W. Langerak, Nikos Darzentas, Sarka Pospisilova, Michael Hallek, MD, Elias Campo, Nicholas Chiorazzi, MD, David Oscier, Gianluca Gaidano, MD PhD, Chrysoula Belessi, Diane F. Jelinek, Stephan Stilgenbauer, MD, Frederic Davi, Richard Rosenquist, Paolo Ghia, Kostas Stamatopoulos

Blood (2015) 126 (23): 5263.

https://doi.org/10.1182/blood.V126.23.5263.5263

Published: 2015

Journal Articles

Recurrent Mutations within the Nfkbie gene: A Novel Mechanism for NF-κB Deregulation in Aggressive Chronic Lymphocytic Leukemia

Blood (2014) 124 (21): 297.

https://doi.org/10.1182/blood.V124.21.297.297

Published: 2014

Journal Articles

Regular Aspirin Use and Risk of Non-Hodgkin Lymphoma: A Prospective Analysis in the Nurses' Health Study

Elsa Brånvall, MD MPH, Karin E Smedby, MD PhD, Bernard A. Rosner, PhD, Edward Giovannucci, MD ScD, Jan-Peter Glossmann, MD MPH, Kimberly A Bertrand, ScD, Honglei Chen, MD PhD, Francine Laden, ScD, Shumin Zhang, MD ScD, Brenda M. Birmann, ScD

Blood (2014) 124 (21): 2990.

https://doi.org/10.1182/blood.V124.21.2990.2990

Published: 2014

Journal Articles

Clinical Impact of Stereotyped Antigen Receptors in Chronic Lymphocytic Leukemia

Panagiotis Baliakas, Anastasia Hadzidimitriou, Lesley-Ann Sutton, Evangelia Minga, Andreas Agathangelidis, Athina Tsanousa, Lydia Scarfo, Zadie Davis, Joy Yan, Tait D. Shanafelt, MD, Karla Plevova, M.S., PhD, Yorick Sandberg, Fie Juhl Vojdeman, Myriam Boudjoghra, Tatiana Tzenou, Maria Chatzouli, Charles C. Chu, PhD, Silvio Veronese, Anne Catherine Gardiner, Larry Mansouri, Karin E Smedby, MD PhD, Lone Pedersen, Denis Moreno, Kirsten van Lom, Veronique Giudicelli, Hana Francova, Florence Nguyen-Khac, MDPhD, Panagiotis Panagiotidis, Gunnar Juliusson, Lefteris Angelis, Achilles Anagnostopoulos, Marie-Paule Lefranc, Monica Facco, Livio Trentin, Mark Catherwood, Marco Montillo, MD, Christian H Geisler, Anton W Langerak, Sarka Pospisilova, Nicholas Chiorazzi, MD, David Oscier, Diane F. Jelinek, Nikos Darzentas, Chrysoula Belessi, Frederic Davi, MD PhD, Richard Rosenquist, Paolo Ghia, MD PhD, Kostas Stamatopoulos, on behalf of ERIC, the European Research Initiative on CLL

Blood (2014) 124 (21): 3280.

https://doi.org/10.1182/blood.V124.21.3280.3280

Published: 2014

NARROW

Outcome By Primary Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A Large, Population-Based Study in Sweden

Nationwide Investigation of Patient Trajectories in Mantle Cell Lymphoma - Initial Data from the Swedish MCL C omplete Project

Encouraging Outcomes with Intensive Chemotherapy for Patients with Primary Mediastinal B-Cell Lymphoma - a Swedish Lymphoma Register Study

Incidence of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Including CNS Relapse in a Population-Based Cohort of 4205 Patients in Sweden

Autologous Stem Cell Transplantation in Mantle Cell Lymphoma - Selection Mechanisms and Survival By Age Group

Evaluation of the NCCN-IPI As a Prognostic Tool in PTCLs

PD-L1 Expression and Gene Amplification in CD30+ Diffuse Large B-Cell Lymphoma (DLBCL): Significance of TP53 Genetic Impact and Clinicopathologic Characteristics

Six Cycles of R-CHOP-21 Is Non-Inferior to 8 Cycles for Treatment of Diffuse Large B-Cell Lymphoma - a Nordic Lymphoma Group Population Based Study

Common Genetic Polymorphisms Contribute to the Association between Non-Melanoma Skin Cancer and Chronic Lymphocytic Leukemia

Genome-Wide DNA Methylation Profiling of Chronic Lymphocytic Leukemia Subsets Carrying Stereotyped B Cell Receptors

EGR2 Mutations in Chronic Lymphocytic Leukemia: A New Bad Player

ATM Mutations in Major Stereotyped CLL Subsets: Enrichment in Subset #2 is Associated with Unfavourable Outcome

Event-Free Survival at 12 Months and Subsequent Overall Survival in Patients with Peripheral T-Cell Lymphoma

CLL with Mutated IGHV4-34 Antigen Receptors Is Clinically Heterogeneous: Antigen Receptor Stereotypy Makes the Difference

Recurrent Mutations within the Nfkbie gene: A Novel Mechanism for NF-κB Deregulation in Aggressive Chronic Lymphocytic Leukemia

Regular Aspirin Use and Risk of Non-Hodgkin Lymphoma: A Prospective Analysis in the Nurses' Health Study

Clinical Impact of Stereotyped Antigen Receptors in Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only